Placebo-Control
Sponsors
Theratechnologies, Augusta University, Nature Cell Co. Ltd., David Grant U.S. Air Force Medical Center, The University of Hong Kong
Conditions
Alzheimer DiseaseAttention ImpairedCardiovascular DiseasesChronic Kidney Disease Stage 3Chronic Kidney Disease Stage 4Chronic Kidney Disease Stage 5DiabetesDiabetic Retinopathy
Phase 1
Phase 4
Unknown Phase
Vitamin K and Glucose Metabolism in Children at Risk for Diabetes (Vita-K 'n' Kids Study)
NCT01972113
Start: 2013-09-30End: 2020-12-30Target: 30Updated: 2019-11-19
Vitamin K to Slow Progression of Dyslipidemia and Diabetes Risk (Vita-K 'n' Kids Study II)
NCT02959762
Start: 2016-10-31End: 2020-12-30Target: 30Updated: 2019-11-20
Vitamin K to Slow Progression of Cardiovascular Disease Risk in Hemodialysis Patients
NCT03311321
Start: 2017-09-13End: 2021-12-30Target: 60Updated: 2019-11-20
Post-Exercise Cardiovascular Responses Following Energy Drink Consumption
CompletedNCT03418077
Start: 2018-05-07End: 2019-05-31Updated: 2020-04-17
Evaluating Clinical Effects of a Spray-Type Bio-absorbable Adhesion Barrier System in Paediatric Patients
CompletedNCT05255081
Start: 2022-03-01End: 2024-04-30Updated: 2024-05-08
Brief Mental Training and Internal Attentional Control
NCT05353231
Start: 2022-05-23End: 2022-12-31Target: 90Updated: 2022-05-24